REZZAYO
- Product NDC
- 70842-240
- 11-digit product format
- 708420240
- Labeler code
- 70842
- Product ID
- 70842-240_2b7bcdc0-0333-42a1-942c-7b2efeb2398a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rezafungin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Melinta Therapeutics, LLC
- Application
- NDA217417
- Marketing category
- NDA
- Marketing start
- 2023-06-09
- Substance
- REZAFUNGIN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Echinocandin Antifungal [EPC], Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- REZZAYO
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REZAFUNGIN | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | G013B5478J |
| Rxcui | 2639160, 2639165 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70842-240-01 | REZZAYO | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 4 |
| 70842-240-01 | REZZAYO | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70842-240 | REZZAYO (REZAFUNGIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MELINTA THERAPEUTICS, LLC] | 2 | Current NDC, 2 package rows | 20241024_90073508-6dca-4d27-aa5a-ed837737c35b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70842-240-01 | 70842024001 | 1 VIAL in 1 CARTON (70842-240-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2023-06-09 | No | No | Current |